Literature DB >> 8403301

Residual flow to the infarct zone as a determinant of infarct size after direct angioplasty.

I P Clements1, T F Christian, S T Higano, R J Gibbons, B J Gersh.   

Abstract

BACKGROUND: In acute myocardial infarction, residual flow to the infarct zone either through antegrade flow in the infarct-related coronary artery or collateral flow from the non-infarct-related arteries is often present before reperfusion therapy. The purpose of this study was to assess the influence of antegrade flow in the infarct-related artery and/or collateral flow to the infarct zone before successful direct angioplasty on infarct size and myocardial salvage in patients with acute evolving myocardial infarction. METHODS AND
RESULTS: Sixty patients with acute evolving myocardial infarction underwent direct successful angioplasty without prior thrombolytic therapy. The myocardium at risk of infarction, the final infarct size, and myocardial salvage were measured by tomographic perfusion imaging with 99mTc sestamibi. Antegrade flow in the infarct-related artery before intervention was graded according to the Thrombolysis in Myocardial Infarction (TIMI) study group classification. Collateral flow to the infarct zone before angioplasty was also graded (0 through 3, 0 being no collateral flow). The presence of even minimal antegrade flow before angioplasty (TIMI grade 1) in the infarct-related artery compared with absent flow was associated with a significant reduction in final infarct size (9 +/- 17% versus 23 +/- 19% of left ventricle, P = .02) and a significant increase in myocardial salvage (23 +/- 16% versus 14 +/- 13% of left ventricle, P = .05) after angioplasty. When antegrade flow in the infarct-related artery was absent before angioplasty, the presence of collateral flow before angioplasty resulted in a significantly smaller final infarct size (P = .01) and more myocardial salvage (P = .05) after angioplasty. Both antegrade infarct-related artery flow and collateral flow to the infarct zone had significant independent ability to predict infarct size after angioplasty. When collateral grade and TIMI grade were added to provide an estimate of residual flow, a model including residual flow, myocardium at risk, and the interaction of residual flow and infarct site explained 83% of the variability in infarct size after angioplasty.
CONCLUSIONS: The presence of antegrade flow in the infarct-related artery and/or collateral flow to the infarct zone before direct angioplasty in acute evolving infarction results in a smaller infarct size after direct successful angioplasty.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403301     DOI: 10.1161/01.cir.88.4.1527

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Spontaneous late improvement of myocardial viability in the chronic infarct zone is possible, depending on persistent TIMI 3 flow and a low grade stenosis of the infarct artery.

Authors:  M Faraggi; G Montalescot; L Sarda; J F Heintz; D Doumit; G Drobinski; I Sotirov; D Le Guludec; D Thomas
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

Review 2.  Treating myocardial infarction in the post-GUSTO era. A European perspective.

Authors:  M J de Boer; F Zijlstra
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

3.  Prognostic significance of the distortion of terminal portion of QRS complex on admission electrocardiogram in ST segment elevation myocardial infarction.

Authors:  Dnyaneshwar V Mulay; Sachin M Mukhedkar
Journal:  Indian Heart J       Date:  2013-11-01

4.  Clinical characteristics of occluded culprit arteries and collaterals in patients with non-ST-segment elevation myocardial infarction and impact on clinical outcomes.

Authors:  Hui-Jeong Hwang; Chang-Bum Park; Jin-Man Cho; Eun-Sun Jin; Il Suk Sohn; Dong-Hee Kim; Chong-Jin Kim
Journal:  Exp Ther Med       Date:  2018-08-13       Impact factor: 2.447

Review 5.  [Cardiac remodeling after myocardial infarction : Clinical practice update].

Authors:  G Ertl; S Brenner; C E Angermann
Journal:  Herz       Date:  2017-02       Impact factor: 1.443

6.  Noninvasive detection of collateral flow to the infarct-related coronary artery in patients after myocardial infarction by Tl-201 tomographic imaging.

Authors:  Pierre Chouraqui; Arik Asman; Victor Guetta; Fathy Daka; Jack Baron; Eli Rozen; Matan Sternberg; Michael Shechter
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

7.  The presence of angiographic collaterals in non-ST elevation myocardial infarction is a predictor of long-term clinical outcomes.

Authors:  Angela M Kloepfer; Lewis C Lipson; Ellen C Keeley
Journal:  Catheter Cardiovasc Interv       Date:  2013-06-25       Impact factor: 2.692

8.  Use of 99mTc-sestamibi gated SPECT to assess the influence of anterograde flow before primary coronary angioplasty on tissue salvage and functional recovery in acute myocardial infarction.

Authors:  Mario Leoncini; Francesco Bellandi; Roberto Sciagrà; Mauro Maioli; Anna Toso; Stelvio Sestini; Angela Coppola; Alberto Mennuti; Roberto Piero Dabizzi; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-19       Impact factor: 9.236

9.  The effects of facilitated primary PCI by guide wire on procedural and clinical outcomes in acute ST-segment elevation myocardial infarction.

Authors:  Volkhard Kurowski; Evangelos Giannitsis; Dirk P Killermann; Uwe K H Wiegand; Ralph Toelg; Hendrik Bonnemeier; Franz Hartmann; Hugo A Katus; Gert Richardt
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

10.  Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow.

Authors:  Seishi Nakamura; Kazuya Takehana; Tetsuro Sugiura; Kengo Hatada; Shinichi Hamada; Junko Asada; Reisuke Yuyama; Jun Mimura; Yusuke Imuro; Hirohiko Kurihara; Masayoshi Fukui; Masato Baden; Toshiji Iwasaka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-19       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.